Identification of an APC Variant in a Patient with Clinical Attenuated Familial Adenomatous Polyposis

Introduction. The objective of this case report is to discuss an unclassified germline variant of the adenomatous polyposis coli (APC) gene identified in an older patient with attenuated familial adenomatous polyposis syndrome (AFAP). Methods. We present a case report of a 66-year-old man diagnosed...

Full description

Saved in:
Bibliographic Details
Main Authors: Andrew T. Schlussel, Susan S. Donlon, Faye A. Eggerding, Ronald A. Gagliano
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Case Reports in Medicine
Online Access:http://dx.doi.org/10.1155/2014/432324
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849396192960577536
author Andrew T. Schlussel
Susan S. Donlon
Faye A. Eggerding
Ronald A. Gagliano
author_facet Andrew T. Schlussel
Susan S. Donlon
Faye A. Eggerding
Ronald A. Gagliano
author_sort Andrew T. Schlussel
collection DOAJ
description Introduction. The objective of this case report is to discuss an unclassified germline variant of the adenomatous polyposis coli (APC) gene identified in an older patient with attenuated familial adenomatous polyposis syndrome (AFAP). Methods. We present a case report of a 66-year-old man diagnosed with AFAP. Colonoscopy found multiple polyps and invasive adenocarcinoma arising in the transverse colon. Samples were tested for mutations in the APC gene. Results. DNA sequencing of germline DNA identified a cytosine (C) to thymine (T) transition at nucleotide 1240, heterozygous. The C to T transition at codon 414 is predicted to convert an arginine residue to a cysteine that is possibly pathogenic. Analysis of the patient’s colon tumor DNA indicated that the tumor had lost the mutant variant allele and retained only the normal allele, suggesting that the variant may not be significant. Conclusions. The p.R414C variant has been described previously as a germline mutation of probable pathogenicity. This substitution should be considered an unclassified variant and possibly not pathogenic. These findings support the need for further genetic testing of tissue, as well as for developing a mechanism for testing all variants, as this could significantly impact the lives of patients and their family members.
format Article
id doaj-art-b1f22d93f6a34519ae93cf2dda43afa8
institution Kabale University
issn 1687-9627
1687-9635
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series Case Reports in Medicine
spelling doaj-art-b1f22d93f6a34519ae93cf2dda43afa82025-08-20T03:39:25ZengWileyCase Reports in Medicine1687-96271687-96352014-01-01201410.1155/2014/432324432324Identification of an APC Variant in a Patient with Clinical Attenuated Familial Adenomatous PolyposisAndrew T. Schlussel0Susan S. Donlon1Faye A. Eggerding2Ronald A. Gagliano3Department of General Surgery, Tripler Army Medical Center, 1 Jarrett White Road, Honolulu, HI 96859, USADepartment of General Surgery, Tripler Army Medical Center, 1 Jarrett White Road, Honolulu, HI 96859, USAHuntington Medical Research Institutes, 99 N. El Molino Avenue, Pasadena, CA 91101-1830, USADepartment of General Surgery, Tripler Army Medical Center, 1 Jarrett White Road, Honolulu, HI 96859, USAIntroduction. The objective of this case report is to discuss an unclassified germline variant of the adenomatous polyposis coli (APC) gene identified in an older patient with attenuated familial adenomatous polyposis syndrome (AFAP). Methods. We present a case report of a 66-year-old man diagnosed with AFAP. Colonoscopy found multiple polyps and invasive adenocarcinoma arising in the transverse colon. Samples were tested for mutations in the APC gene. Results. DNA sequencing of germline DNA identified a cytosine (C) to thymine (T) transition at nucleotide 1240, heterozygous. The C to T transition at codon 414 is predicted to convert an arginine residue to a cysteine that is possibly pathogenic. Analysis of the patient’s colon tumor DNA indicated that the tumor had lost the mutant variant allele and retained only the normal allele, suggesting that the variant may not be significant. Conclusions. The p.R414C variant has been described previously as a germline mutation of probable pathogenicity. This substitution should be considered an unclassified variant and possibly not pathogenic. These findings support the need for further genetic testing of tissue, as well as for developing a mechanism for testing all variants, as this could significantly impact the lives of patients and their family members.http://dx.doi.org/10.1155/2014/432324
spellingShingle Andrew T. Schlussel
Susan S. Donlon
Faye A. Eggerding
Ronald A. Gagliano
Identification of an APC Variant in a Patient with Clinical Attenuated Familial Adenomatous Polyposis
Case Reports in Medicine
title Identification of an APC Variant in a Patient with Clinical Attenuated Familial Adenomatous Polyposis
title_full Identification of an APC Variant in a Patient with Clinical Attenuated Familial Adenomatous Polyposis
title_fullStr Identification of an APC Variant in a Patient with Clinical Attenuated Familial Adenomatous Polyposis
title_full_unstemmed Identification of an APC Variant in a Patient with Clinical Attenuated Familial Adenomatous Polyposis
title_short Identification of an APC Variant in a Patient with Clinical Attenuated Familial Adenomatous Polyposis
title_sort identification of an apc variant in a patient with clinical attenuated familial adenomatous polyposis
url http://dx.doi.org/10.1155/2014/432324
work_keys_str_mv AT andrewtschlussel identificationofanapcvariantinapatientwithclinicalattenuatedfamilialadenomatouspolyposis
AT susansdonlon identificationofanapcvariantinapatientwithclinicalattenuatedfamilialadenomatouspolyposis
AT fayeaeggerding identificationofanapcvariantinapatientwithclinicalattenuatedfamilialadenomatouspolyposis
AT ronaldagagliano identificationofanapcvariantinapatientwithclinicalattenuatedfamilialadenomatouspolyposis